EUVIMEDEUVIMED entdecken
Crossref

Persistencia de uso, inercia clínica y efectividad del tratamiento en un grupo de pacientes con dislipidemia

Luis F. Valladales-Restrepo, Camilo A. Constain-Mosquera, Dary C. Méndez-Grisales, Luisa F. Poveda-Martínez, Manuela Henao-Martínez, Rubén D. Jiménez-Hurtado, Santiago Rubio-Londoño, Luz A. Quintero-González, Germán C. Giraldo-González, Jorge E. Machado-Alba

Revista Colombiana de Cardiología · 03.06.2026 · 33 (2)

DOI: 10.24875/rccar.25000012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revista Colombiana de Cardiología, online erschienen am 03.06.2026. Verfasst von Luis F. Valladales-Restrepo und 9 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Lipid-lowering therapy reduces the risk of atherosclerotic cardiovascular disease, but effectiveness may depend on persistence, adherence and clinical inertia.

Objective

To determine the persistence of use, effectiveness and clinical inertia of lipid-lowering therapy in a group of patients diagnosed with dyslipidemia affiliated to Colombian Health Care System.

Methods

Observational retrospective longitudinal study of patients diagnosed with dyslipidemia affiliated to Colombian Health Care System. Sociodemographic, clinical (cardiovascular risk) and pharmacological variables were identified. The effectiveness of the treatment, the presence of clinical inertia and the persistence of use were determined.

Results

A total of 381 patients were analyzed, with a median age of 61.0 years, and 63.5% were women. A total of 42.0% of patients had high or very high cardiovascular risk and were treated mainly with statins (83.7%). A total of 31.5% reached the treatment goal, and 52.0% of those who did not achieve control presented clinical inertia. A total of 58.3% persisted with lipid-lowering therapy at 12 months, having a high or very high cardiovascular risk (OR: 1.81; 95% CI: 1.05-3.10), receiving comedications (OR: 2.06; 95% CI: 1.01-4.17) and having treatment adjustments (OR: 4.56; 95% CI: 2.60-7.99) were associated with increasing this probability.

Conclusions

The identification of the effectiveness, clinical inertia and persistence of the use of lipid-lowering drugs in each group of patients treated should allow making the necessary adjustments to achieve the goals and guarantee adherence to treatment.

Zitieren

APA

Valladales-Restrepo, L. F., Constain-Mosquera, C. A., Méndez-Grisales, D. C., Poveda-Martínez, L. F., Henao-Martínez, M., Jiménez-Hurtado, R. D., Rubio-Londoño, S., Quintero-González, L. A., Giraldo-González, G. C., & Machado-Alba, J. E. (2026). Persistencia de uso, inercia clínica y efectividad del tratamiento en un grupo de pacientes con dislipidemia. Revista Colombiana de Cardiología, 33(2). https://doi.org/10.24875/rccar.25000012

Vancouver

Valladales-Restrepo LF, Constain-Mosquera CA, Méndez-Grisales DC, Poveda-Martínez LF, Henao-Martínez M, Jiménez-Hurtado RD, et al. Persistencia de uso, inercia clínica y efectividad del tratamiento en un grupo de pacientes con dislipidemia. Revista Colombiana de Cardiología. 2026;33(2). doi:10.24875/rccar.25000012

BibTeX
@article{ValladalesRestrepo2026,
  author = {Valladales-Restrepo, Luis F. and Constain-Mosquera, Camilo A. and Méndez-Grisales, Dary C. and Poveda-Martínez, Luisa F. and Henao-Martínez, Manuela and Jiménez-Hurtado, Rubén D. and Rubio-Londoño, Santiago and Quintero-González, Luz A. and Giraldo-González, Germán C. and Machado-Alba, Jorge E.},
  title = {Persistencia de uso, inercia clínica y efectividad del tratamiento en un grupo de pacientes con dislipidemia},
  journal = {Revista Colombiana de Cardiología},
  year = {2026},
  volume = {33},
  number = {2},
  doi = {10.24875/rccar.25000012}
}
Kostenlos starten →